Aura Biosciences Analyst Ratings
Aura Biosciences Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/10/2023 | 154.35% | JMP Securities | $21 → $19 | Maintains | Market Outperform |
07/27/2023 | 207.9% | Scotiabank | → $23 | Initiates Coverage On | → Sector Outperform |
03/16/2023 | 234.67% | JMP Securities | $30 → $25 | Maintains | Outperform |
11/11/2022 | 301.61% | JMP Securities | $26 → $30 | Maintains | Market Outperform |
07/19/2022 | 248.06% | JMP Securities | → $26 | Initiates Coverage On | → Market Outperform |
11/23/2021 | 408.7% | BTIG | → $38 | Initiates Coverage On | → Buy |
11/23/2021 | 368.54% | Evercore ISI Group | → $35 | Initiates Coverage On | → Outperform |
11/23/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
11/23/2021 | 435.48% | SVB Leerink | → $40 | Initiates Coverage On | → Outperform |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
11/10/2023 | 154.35% | JMP 证券 | 21 美元 → 19 美元 | 维护 | 市场表现跑赢大盘 |
07/27/2023 | 207.9% | 丰业银行 | → 23 美元 | 启动覆盖范围开启 | → 板块表现跑赢大盘 |
03/16/2023 | 234.67% | JMP 证券 | 30 美元 → 25 美元 | 维护 | 跑赢大盘 |
11/11/2022 | 301.61% | JMP 证券 | 26 美元 → 30 美元 | 维护 | 市场表现跑赢大盘 |
2022 年 7 月 19 日 | 248.06% | JMP 证券 | → 26 美元 | 启动覆盖范围开启 | → 市场跑赢大盘 |
11/23/2021 | 408.7% | BTIG | → 38 美元 | 启动覆盖范围开启 | → 购买 |
11/23/2021 | 368.54% | Evercore ISI 集团 | → 35 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
11/23/2021 | — | Cowen & Co. | 启动覆盖范围开启 | → 跑赢大盘 | |
11/23/2021 | 435.48% | SVB Leerink | → 40 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
What is the target price for Aura Biosciences (AURA)?
Aura Biosciences(AURA)的目标价格是多少?
The latest price target for Aura Biosciences (NASDAQ: AURA) was reported by JMP Securities on November 10, 2023. The analyst firm set a price target for $19.00 expecting AURA to rise to within 12 months (a possible 154.35% upside). 4 analyst firms have reported ratings in the last year.
JMP Securities于2023年11月10日公布了光环生物科学(纳斯达克股票代码:AURA)的最新目标股价。该分析公司将目标股价定为19.00美元,预计AURA将在12个月内升至12个月内(可能上涨154.35%)。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Aura Biosciences (AURA)?
Aura Biosciences(AURA)的最新分析师评级是多少?
The latest analyst rating for Aura Biosciences (NASDAQ: AURA) was provided by JMP Securities, and Aura Biosciences maintained their market outperform rating.
Aura Biosciences(纳斯达克股票代码:AURA)的最新分析师评级由JMP Securities提供,Aura Biosciences维持其跑赢大盘的评级。
When is the next analyst rating going to be posted or updated for Aura Biosciences (AURA)?
Aura Biosciences(AURA)的下一次分析师评级何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aura Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aura Biosciences was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与Aura Biosciences的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月做一次这样的评级,因此每家公司每年应该获得4次评级。Aura Biosciences的最新评级是在2023年11月10日发布的,因此您应该预计下一个评级将在2024年11月10日左右公布。
Is the Analyst Rating Aura Biosciences (AURA) correct?
分析师评级Aura Biosciences(AURA)是否正确?
While ratings are subjective and will change, the latest Aura Biosciences (AURA) rating was a maintained with a price target of $21.00 to $19.00. The current price Aura Biosciences (AURA) is trading at is $7.47, which is out of the analyst's predicted range.
尽管评级是主观的,并且会发生变化,但最新的Aura Biosciences(AURA)评级维持不变,目标股价为21.00美元至19.00美元。Aura Biosciences(AURA)目前的交易价格为7.47美元,超出了分析师的预期区间。